{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:02:06Z","timestamp":1783576926600,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["38452"],"award-info":[{"award-number":["38452"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["122S204"],"award-info":[{"award-number":["122S204"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09672-z","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:57:54Z","timestamp":1754463474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-3244","authenticated-orcid":false,"given":"Fatih","family":"Akboga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-9555","authenticated-orcid":false,"given":"Fehmi","family":"Hindilerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1353-2367","authenticated-orcid":false,"given":"Ipek Yonal","family":"Hindilerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-6162","authenticated-orcid":false,"given":"Emine","family":"Gulturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0721-6213","authenticated-orcid":false,"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-0855","authenticated-orcid":false,"given":"Metin Yusuf","family":"Gelmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"9672_CR1","doi-asserted-by":"publisher","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","volume":"3","author":"TJ Kipps","year":"2017","unstructured":"Kipps TJ, et al. Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 2017;3:16096.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"9672_CR2","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1182\/blood-2009-06-228981","volume":"114","author":"JA Burger","year":"2009","unstructured":"Burger JA, Gandhi V. The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions. Blood. 2009;114(12):2560\u20131 (author reply 2561\u20132).","journal-title":"Blood"},{"issue":"12","key":"9672_CR3","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.3109\/10428194.2014.898758","volume":"55","author":"C Nabhan","year":"2014","unstructured":"Nabhan C, et al. The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive surveillance, epidemiology, and end results analysis in the modern era. Leuk Lymphoma. 2014;55(12):2778\u201384.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"9672_CR4","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41375-020-0873-2","volume":"34","author":"PM Roessner","year":"2020","unstructured":"Roessner PM, Seiffert M. T-cells in chronic lymphocytic leukemia: guardians or drivers of disease? Leukemia. 2020;34(8):2012\u201324.","journal-title":"Leukemia"},{"issue":"10","key":"9672_CR5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3109\/10428194.2010.503820","volume":"51","author":"AP Gonzalez-Rodriguez","year":"2010","unstructured":"Gonzalez-Rodriguez AP, et al. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia. Leuk Lymphoma. 2010;51(10):1829\u201336.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"9672_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cell.2016.01.021","volume":"165","author":"R Basu","year":"2016","unstructured":"Basu R, et al. Cytotoxic t cells use mechanical force to potentiate target cell killing. Cell. 2016;165(1):100\u201310.","journal-title":"Cell"},{"issue":"12","key":"9672_CR7","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1002\/eji.200636746","volume":"37","author":"MF Quigley","year":"2007","unstructured":"Quigley MF, et al. CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles. Eur J Immunol. 2007;37(12):3352\u201362.","journal-title":"Eur J Immunol"},{"issue":"5","key":"9672_CR8","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1172\/JCI96207","volume":"128","author":"S Ferrando-Martinez","year":"2018","unstructured":"Ferrando-Martinez S, et al. Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest. 2018;128(5):2089\u2013103.","journal-title":"J Clin Invest"},{"key":"9672_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3389\/fimmu.2019.01322","volume":"10","author":"KM Valentine","year":"2019","unstructured":"Valentine KM, Hoyer KK. CXCR5+ CD8 T cells: protective or pathogenic? Front Immunol. 2019;10:1322.","journal-title":"Front Immunol"},{"key":"9672_CR10","doi-asserted-by":"crossref","unstructured":"E Jifu, et al. CD8(+)CXCR5(+) T cells in tumor-draining lymph nodes are highly activated and predict better prognosis in colorectal cancer. Hum Immunol. 2018;79(6):446\u201352.","DOI":"10.1016\/j.humimm.2018.03.003"},{"issue":"1","key":"9672_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexcr.2017.09.039","volume":"361","author":"M Bai","year":"2017","unstructured":"Bai M, et al. CXCR5(+) CD8(+) T cells potently infiltrate pancreatic tumors and present high functionality. Exp Cell Res. 2017;361(1):39\u201345.","journal-title":"Exp Cell Res"},{"key":"9672_CR12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3389\/fimmu.2018.02287","volume":"9","author":"J Shen","year":"2018","unstructured":"Shen J, et al. A subset of CXCR5(+)CD8(+) T cells in the germinal centers from human tonsils and lymph nodes help B cells produce immunoglobulins. Front Immunol. 2018;9: 2287.","journal-title":"Front Immunol"},{"issue":"1","key":"9672_CR13","doi-asserted-by":"publisher","first-page":"111892","DOI":"10.1016\/j.yexcr.2020.111892","volume":"389","author":"J Xing","year":"2020","unstructured":"Xing J, et al. Inverse relationship between CD40L expression and cytolytic molecule expression by CD8(+)CXCR5(+) T follicular cytotoxic cells in colorectal cancer. Exp Cell Res. 2020;389(1): 111892.","journal-title":"Exp Cell Res"},{"key":"9672_CR14","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, et al. CD4(+)T cells: differentiation and functions. Clin Dev Immunol. 2012;2012:925135.","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"9672_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","volume":"19","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003;19(5):641\u20134.","journal-title":"Immunity"},{"issue":"1","key":"9672_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1753425917739681","volume":"24","author":"X Meng","year":"2018","unstructured":"Meng X, Yang B, Suen WC. Prospects for modulating the CD40\/CD40L pathway in the therapy of the hyper-IgM syndrome. Innate Immun. 2018;24(1):4\u201310.","journal-title":"Innate Immun"},{"key":"9672_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.22.012703.104533","volume":"22","author":"SA Quezada","year":"2004","unstructured":"Quezada SA, et al. CD40\/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol. 2004;22:307\u201328.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"9672_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2567.2011.03487.x","volume":"134","author":"EK Deenick","year":"2011","unstructured":"Deenick EK, Ma CS. The regulation and role of T follicular helper cells in immunity. Immunology. 2011;134(4):361\u20137.","journal-title":"Immunology"},{"issue":"6","key":"9672_CR19","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.cellsig.2013.03.010","volume":"25","author":"GU Hong","year":"2013","unstructured":"Hong GU, et al. IgE production in CD40\/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma. Cell Signal. 2013;25(6):1514\u201325.","journal-title":"Cell Signal"},{"key":"9672_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2015.02.023","volume":"754","author":"GU Hong","year":"2015","unstructured":"Hong GU, et al. IgE and IgA produced by OX40-OX40L or CD40-CD40L interaction in B cells-mast cells re-activate FcepsilonRI or FcalphaRI on mast cells in mouse allergic asthma. Eur J Pharmacol. 2015;754:199\u2013210.","journal-title":"Eur J Pharmacol"},{"issue":"7620","key":"9672_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature19317","volume":"537","author":"R He","year":"2016","unstructured":"He R, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537(7620):412\u201328.","journal-title":"Nature"},{"issue":"10","key":"9672_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ni.3543","volume":"17","author":"YA Leong","year":"2016","unstructured":"Leong YA, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17(10):1187\u201396.","journal-title":"Nat Immunol"},{"issue":"15","key":"9672_CR23","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1182\/bloodadvances.2018017244","volume":"2","author":"KS Le","year":"2018","unstructured":"Le KS, et al. CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas. Blood Adv. 2018;2(15):1889\u2013900.","journal-title":"Blood Adv"},{"issue":"2","key":"9672_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1084\/jem.20091738","volume":"207","author":"MA Linterman","year":"2010","unstructured":"Linterman MA, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med. 2010;207(2):353\u201363.","journal-title":"J Exp Med"},{"issue":"10","key":"9672_CR25","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.immuni.2021.08.028","volume":"54","author":"L Duan","year":"2021","unstructured":"Duan L, et al. Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation. Immunity. 2021;54(10):2256-2272e6.","journal-title":"Immunity"},{"key":"9672_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.intimp.2018.07.002","volume":"62","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, et al. CXCR5(+) CD8 T cells displayed higher activation potential despite high PD-1 expression, in tumor-involved lymph nodes from patients with thyroid cancer. Int Immunopharmacol. 2018;62:114\u20139.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"9672_CR27","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1038\/s41375-019-0464-2","volume":"33","author":"F Chu","year":"2019","unstructured":"Chu F, et al. CXCR5(+)CD8(+) T cells are a distinct functional subset with an antitumor activity. Leukemia. 2019;33(11):2640\u201353.","journal-title":"Leukemia"},{"key":"9672_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.intimp.2017.06.020","volume":"50","author":"J Tang","year":"2017","unstructured":"Tang J, et al. CXCR5(+)CD8(+) T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma. Int Immunopharmacol. 2017;50:146\u201351.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"9672_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12308-022-00497-5","volume":"15","author":"MY Gelmez","year":"2022","unstructured":"Gelmez MY, et al. High expression of OX-40, ICOS, and low expression PD-L1 of follicular helper and follicular cytotoxic T cells in chronic lymphocytic leukemia. J Hematop. 2022;15(3):117\u201329.","journal-title":"J Hematop"},{"key":"9672_CR30","doi-asserted-by":"publisher","first-page":"1034764","DOI":"10.3389\/fmed.2022.1034764","volume":"9","author":"CN Turner","year":"2022","unstructured":"Turner CN, Mullins GN, Hoyer KK. CXCR5(+)CD8 T cells: Potential immunotherapy targets or drivers of immune-mediated adverse events? Front Med (Lausanne). 2022;9:1034764.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"9672_CR31","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"Brummelman J, et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors. J Exp Med. 2018;215(10):2520\u201335.","journal-title":"J Exp Med"},{"key":"9672_CR32","doi-asserted-by":"publisher","first-page":"102690","DOI":"10.1016\/j.jaut.2021.102690","volume":"123","author":"KM Valentine","year":"2021","unstructured":"Valentine KM, et al. CD8 follicular t cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties. J Autoimmun. 2021;123: 102690.","journal-title":"J Autoimmun"},{"issue":"5","key":"9672_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/08820139.2017.1288241","volume":"46","author":"MY Gelmez","year":"2017","unstructured":"Gelmez MY, et al. Investigation of AID, Dicer, and Drosha expressions in patients with chronic lymphocytic leukemia. Immunol Invest. 2017;46(5):433\u201346.","journal-title":"Immunol Invest"},{"issue":"2","key":"9672_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/10428194.2013.803225","volume":"55","author":"MY Gelmez","year":"2014","unstructured":"Gelmez MY, et al. Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status. Leuk Lymphoma. 2014;55(2):326\u201330.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"9672_CR35","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","volume":"179","author":"S Kuchen","year":"2007","unstructured":"Kuchen S, et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol. 2007;179(9):5886\u201396.","journal-title":"J Immunol"},{"issue":"1","key":"9672_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaci.2017.07.046","volume":"142","author":"ZI Komlosi","year":"2018","unstructured":"Komlosi ZI, et al. Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol. 2018;142(1):178-194e11.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9672_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/eji.202048761","volume":"51","author":"T Hofland","year":"2021","unstructured":"Hofland T, et al. Human CXCR5(+) PD-1(+) CD8 T cells in healthy individuals and patients with hematologic malignancies. Eur J Immunol. 2021;51(3):703\u201313.","journal-title":"Eur J Immunol"},{"issue":"6","key":"9672_CR38","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1007\/s13277-013-0937-2","volume":"34","author":"Z Cha","year":"2013","unstructured":"Cha Z, et al. Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia. Tumour Biol. 2013;34(6):3579\u201385.","journal-title":"Tumour Biol"},{"key":"9672_CR39","doi-asserted-by":"publisher","first-page":"674492","DOI":"10.3389\/fonc.2021.674492","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, et al. Altered T follicular helper cell subsets and function in chronic lymphocytic leukemia. Front Oncol. 2021;11: 674492.","journal-title":"Front Oncol"},{"key":"9672_CR40","doi-asserted-by":"publisher","first-page":"612244","DOI":"10.3389\/fimmu.2020.612244","volume":"11","author":"E Vlachonikola","year":"2020","unstructured":"Vlachonikola E, Stamatopoulos K, Chatzidimitriou A. T cells in chronic lymphocytic leukemia: a two-edged sword. Front Immunol. 2020;11: 612244.","journal-title":"Front Immunol"},{"issue":"5","key":"9672_CR41","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3324\/haematol.2020.267914","volume":"106","author":"FS Peters","year":"2021","unstructured":"Peters FS, et al. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective. Haematologica. 2021;106(5):1234\u201343.","journal-title":"Haematologica"},{"issue":"5","key":"9672_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3324\/haematol.2013.098459","volume":"99","author":"FJ Gassner","year":"2014","unstructured":"Gassner FJ, et al. Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia. Haematologica. 2014;99(5):67\u20139.","journal-title":"Haematologica"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09672-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09672-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09672-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:02:16Z","timestamp":1770192136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09672-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9672"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09672-z","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Board approval of Istanbul University Faculty of Medicine (Decision No; 587348, and dated September 24, 2021) was obtained, and the study was performed in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have nothing to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}